{"ticker": {"uuid": "09e0533a-734a-4441-bcc3-9905c0d6c444", "symbol": "PYFA", "name": "PT Pyridam Farma Tbk", "exchange": "JKT", "country": "ID", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "ABL acts for ASX-listed Probiotec on its proposed acquisition by Indonesian-listed Pyridam", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNdWNaaUI3SjZVOHlGTERGQmxIRGl3azZuNk5LVi1FRlg4REpVUVpHRlVxT0s0REF1N1BibVhac0p2WmFpV2JBU3V3aEQyN3lmV1dPYllReVVKSm5VOFJHSWRwNlJieF83dXVrMFJCa1l0NVFuWDg3MDF0TC1MVVl3UUw3TGtISWEzTXFYRFpkcG81M1RuLWUxc2UtcmFLWHl1QkRUTDhLcUVvQWs?oc=5", "source_name": "Arnold Bloch Leibler", "published_at": "2023-12-22T08:00:00+00:00", "published_display": "22 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyridam Farma Plans To Acquire Companies In Australia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiR0FVX3lxTE0xTDJRQzB2eHhaeWZKekZVbEYyVWI1cC1ZY1VsakFOZzlXaHA0NlVFWjFfT015bEpBZmd5ZWxtZlZ5cG8tZjRV0gFCQVVfeXFMT1JMV2N3SC05dnJXd0paVTA4UWpicGNoQWhpY1hFdGd3cE1Nc2ZCYk1sbEtYalRKN2hTWEhKc09JZjZn?oc=5", "source_name": "VOI.id", "published_at": "2023-12-22T08:00:00+00:00", "published_display": "22 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ABL acts for ASX-listed Probiotec on its proposed acquisition by Indonesian-listed Pyridam", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNdWNaaUI3SjZVOHlGTERGQmxIRGl3azZuNk5LVi1FRlg4REpVUVpHRlVxT0s0REF1N1BibVhac0p2WmFpV2JBU3V3aEQyN3lmV1dPYllReVVKSm5VOFJHSWRwNlJieF83dXVrMFJCa1l0NVFuWDg3MDF0TC1MVVl3UUw3TGtISWEzTXFYRFpkcG81M1RuLWUxc2UtcmFLWHl1QkRUTDhLcUVvQWs?oc=5", "source_name": "Arnold Bloch Leibler", "published_at": "2023-12-22T08:00:00+00:00", "published_display": "22 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pyridam Farma Plans To Acquire Companies In Australia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiR0FVX3lxTE0xTDJRQzB2eHhaeWZKekZVbEYyVWI1cC1ZY1VsakFOZzlXaHA0NlVFWjFfT015bEpBZmd5ZWxtZlZ5cG8tZjRV0gFCQVVfeXFMT1JMV2N3SC05dnJXd0paVTA4UWpicGNoQWhpY1hFdGd3cE1Nc2ZCYk1sbEtYalRKN2hTWEhKc09JZjZn?oc=5", "source_name": "VOI.id", "published_at": "2023-12-22T08:00:00+00:00", "published_display": "22 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 45, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 58, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 202.0, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 4.1, "twelve_week_move": -41.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.928788, "market_dynamics_buy_signal": false, "relative_strength": -36.481883, "fair_value_gap": -54.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 48.9882, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +4.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 40, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Arnold Bloch Leibler", "count": 1}, {"label": "VOI.id", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 1}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, +4.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ABL acts for ASX-listed Probiotec on its proposed acquisition by Indonesian-listed Pyridam"}], "updated_at": "2026-07-18T13:12:17.525171+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}